Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

SG&A

Share-based compensation expense

Asset impairment and restructuring costs

Expected credit losses on financial assets and related charges

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Canopy Growth

Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

Revenue

Cost of revenue

Gross profit

Operating expenses

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Canopy Growth Corp. engages in the production, distribution, and sale of cannabis and cannabinoid-based products for both adult-use and medical purposes. The firm operates through the following segments: Canada Cannabis, Rest-of-world Cannabis, Storz and Bickel, BioSteel, This Works, and Other. The Canada Cannabis segment includes the production, distribution, and sale of cannabis, hemp, and cannabis products in Canada. The Rest-of-world Cannabis segment focuses on production and sale of cannabis, hemp, and cannabis products internationally. The Storz and Bickel segment produces and sells vaporizers. The BioSteel segment refers to the sale of consumer packaged goods including sports nutrition beverages, hydration mixes, proteins, and other specialty nutrition products. The This Works segment includes the production and sale of beauty, skincare, wellness, and sleep products, some of which have been blended with hemp-derived CBD isolate. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

A major investment bank thinks the cannabis company's shares are a compelling bargain.

Canopy Growth Stock Soars on Analyst Upgrade

Have marijuana Stocks Finally Bottomed out?

Paycom Software

Kiniksa Pharmaceuticals Ltd

A much-needed vote of confidence lifted an entire industry.

Why Canopy Growth, Kiniksa Pharmaceuticals, and Paycom Software Jumped Today

By Javier Hasse and Natan Ponieman. Canopy Growth Corp (NYSE: CGC) released second-quarter financial results that sent the stock trading lower last week.

Exclusive: Canopy Growth's CEO On The Cannabis Company's Stock Price, Growth Potential, Global Footprint

Brink's

ConocoPhillips

Intelsat

QUALCOMM

Each trading day brings that many more new ideas and decisions for traders and investors alike.

5 Special Situations Where Analysts See Very Strong Returns

Aurora Cannabis

HEXO Corp

Several factors are behind the nice rebounds for these Canadian marijuana stocks.

Why Aurora Cannabis, Canopy Growth, and HEXO Shares Are Jumping Today

An analyst on Wednesday said "the worst is over" for Canadian weed giant Canopy Growth as Wall Street's expectations come down to Earth.
The post Marijuana Stocks Rally As Analyst Says 'The Worst Is Over' For Canopy Growth appeared first on Investor's Business Daily.

Marijuana Stocks Rally As Analyst Says 'The Worst Is Over' For Canopy Growth

Canopy Growth Corp's (NYSE: CGC) shares have fallen 65% in the last six months. On Wednesday, the cannabis stock received an upgrade from Bank of America Merrill Lynch, which said Canopy is poised to meet Street expectations.

'Worst Looks Over' For Canopy Growth, Bank Of America Says In Upgrade

Neptune Wellness Solutions Inc.

Neptune Wellness Solutions Inc. NEPT, +8.84% said Wednesday it has reached a mutual agreement with Canopy Growth Corp.s CGC, +7.74% WEED, +8.15% to amend and restate their cannabis processing agreement.

Neptune Wellness and Canopy Growth agree to amend terms of cannabis processing deal

The brokerage upgraded the cannabis producer to buy said the stock's 2019 swoon has tempered valuation and earnings estimates.

After a 60% drop in 6 months, Bank of America says buy pot stock Canopy

Aphria

Cronos Group

CannTrust Holdings

This Billionaire Money Manager Bought 6 Cannabis Stocks in the Third Quarter

OrganiGram Holdings Inc.

Tilray Brands

One retail cannabis store for every 600,000 residents simply isn't enough in Canada's heaviest-populated province.

Blame It on Ontario: Why 1 Province Is the Main Culprit Behind the Canadian Cannabis Industry's Woes

Okta

Investors got a buzz from Canopy Growth and Okta shares.

2 Stocks That Soared Higher on Tuesday

With marijuana legalized in Canada, these penny stocks offer direct exposure and could help you get a piece of the pot.

10 Canadian Marijuana Stocks for Your Portfolio

Marijuana stocks have been gutted this year. But a new survey finds that believers still exist — even if fewer of them make money on the industry.

Marijuana Stocks Are Flailing, But Survey Finds Believers Hang On

Fate Of The Big 3 Canadian Cannabis Producers

Curaleaf Holdings, Inc.

An ETF could be a safer way to invest in the industry, but whether it's worth your money is an entirely different issue.

Does a Marijuana ETF Belong in Your Portfolio?

Canopy Growth (CGC) reports mixed fiscal second-quarter results on strength in its core segments.

Canopy Growth (CGC) Q2 Earnings & Revenues Miss Estimates

Following a weak earnings report investors would be wise not to believe in Cannabis 2.0, but rather a bearish CGC stock chart with increased downside risk.

Now More Than Ever, Keep Away from Canopy Growth Stock

In a week chock-full of losers, one Canadian cannabis producer appears to be the biggest loser of all.

Which Top Canadian Marijuana Stock Was the Biggest Earnings Week Loser?

Greenlane Holdings

Akerna Corp

Amplify Alternative Harvest ETF

SNDL Inc.

Are marijuana stocks on U.S. exchanges a good buy now?

Are These Marijuana Stocks A Good Buy Now? Look Past The Hype

Over the last 12 months, Canopy Growth Corp  (NYSE: CGC) (TSE: WEED) shares have fallen 55%.

Canopy Growth Analysts Lower Price Targets After Q2 Report

Faith in Canopy Growth stock is dwindling, but that doesn't necessarily make it buy-worthy. Here's why CGC requires caution going forward.

Canopy Growth Stock May Be Too Dangerous to Buy Now

Constellation Brands

The Canadian marijuana producer reported another quarter of heavy losses, and markets were not forgiving.

As Canopy Growth Loses $282.7 Million, Constellation Brand’s Headache Continues

"Cannabis 2.0" could be the catalyst to save CGC stock. But other factors remain at play.

‘Cannabis 2.0’ May Not Be Enough to Save Canopy Growth Stock

News for Canopy Growth Stock (CGC)